Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
Codexis
(https://codexis.com) 📸 Data Snapshot: May 29, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Codexis | RNA Manufacturer | Enzyme Biocatalysis Solutions (https://codexis.com)
Title
Codexis | RNA Manufacturer | Enzyme Biocatalysis Solutions
Meta
Codexis: RNA manufacturing and custom enzyme engineering for pharmaceuticals and siRNA therapeutics.
H1 Transforming Therapeutic Manufacturing
H2 Notifications
H2 Making the Impossible, Manufacturable
H2 Unlock Therapeutic Possibilities at Scale
H2 RNA manufacturing
H2 Pharma biocatalysis
H2 Molecular biology and diagnostic applications
H2 Start the conversation with Codexis
H2 With Proven Science, Nothing is Unreachable.
H2 Explore Real-World Solutions
H3 RNA Manufacturing Services
H3 Pharma Biocatalysis
H3 Molecular Biology and Diagnostic Applications
H3 Codexis signs agreement for cardiovascular indication
H3 Codexis Featured in CBS News' Economy 4.0
H3 Enabling In-Process Control with Analytical Monitoring After Each Cycle
H3 Scaling RNA Therapeutics Sustainably
H3 Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis
H3 Enzymes to Enable a Biocatalytic Cascade for Small Molecule API
H3 Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis
H3 Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis
H4 Find out more about our solutions
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Expert Solutions | Codexis Services | siRNA Therapeutics (https://codexis.com/expert-solutions/)
Title
Expert Solutions | Codexis Services | siRNA Therapeutics
Meta
Explore Codexis' expert solutions in siRNA therapeutics and enzyme engineering for pharma.
H1 Expert Solutions Built on Innovation
H2 Answering Your Key Questions
H2 The Scientific Legacy Behind the Solution
H2 Platforms Built for Technical Edge
H2 Explore Industry-Transforming Innovation
H2 We're Paving Your Path to the Future
H3 RNA Manufacturing Services
H3 Pharma Biocatalysis
H3 Molecular Biology and Diagnostic Applications
H3 RNA Manufacturing Services
H3 Pharma Biocatalysis
H3 Molecular Biology and Diagnostic Applications
H3 20+ years
H3 16+ drugs
H3 250+ patents
H3 100+ enzymes
H3 8 and counting
H3 What industries do you serve?
H3 Which stages of development and manufacturing can Codexis support?
H3 Do you offer flexible IP models?
H3 What is the ECO Synthesis® Manufacturing Platform?
H3 ECO Synthesis® Manufacturing Platform
H3 CodeEvolver® Technology Platform
H3 Enabling In-Process Control with Analytical Monitoring After Each Cycle
H3 Scaling RNA Therapeutics Sustainably
H3 Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis
H3 Enzymes to Enable a Biocatalytic Cascade for Small Molecule API
H3 Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis
H3 Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis
H4 Find out more about our solutions
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Contact Us | Codexis Address | Codexis (https://codexis.com/contact-us/)
Title
Contact Us | Codexis Address | Codexis
Meta
Contact Codexis for locations, address information, partnership opportunities or any other questions you may have.
H1 The Partner for Progress
H2 Address
H2 Sales Inquires
H2 Media Inquires
H3 RNA Manufacturing Services
H3 Pharma Biocatalysis
H3 Molecular Biology and Diagnostic Applications
H4 Find out more about our solutions
NAV_HEADER_HEADING_REPEATED_BODY_FOOTER Transformational Technologies | CodeEvolver® | Codexis (https://codexis.com/transformational-technologies/)
Title
Transformational Technologies | CodeEvolver® | Codexis
Meta
Discover Codexis' innovative technologies which include our CodeEvolver® platform and our ECO Synthesis™ Technology.
H1 Modernizing Manufacturing for What's Next
H2 Every Capability is Intentionally Engineered for Technical Edge
H2 Platforms Built on Industry-Defining Science
H2 Combining Bold Innovation with Scientific Legacy
H2 Explore Our Engineered Advantage
H2 Discover the Engine Powering Scalable Solutions
H3 RNA Manufacturing Services
H3 Pharma Biocatalysis
H3 Molecular Biology and Diagnostic Applications
H3 CodeEvolver Technology Platform
H3 ECO Synthesis Manufacturing Platform
H3 Enabling In-Process Control with Analytical Monitoring After Each Cycle
H3 Scaling RNA Therapeutics Sustainably
H3 Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis
H3 Enzymes to Enable a Biocatalytic Cascade for Small Molecule API
H3 Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis
H3 Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis
H4 Find out more about our solutions
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://codexis.com) Codexis | RNA Manufacturer | Enzyme Biocatalysis Solutions
[H1] Transforming Therapeutic Manufacturing From ‘what if’ to ‘what is’, we deliver next-gen manufacturing for molecules that can’t wait. Explore our solutions [IMG: graphic] [H2] Notifications [H3] Codexis signs agreement for cardiovascular indication Codexis signs agreement to manufacture 50 g siRNA to support preclinical work using the ECO Synthesis Manufacturing Platform for cardiovascular indication. Read the press release [H3] Codexis Featured in CBS News' Economy 4.0 Codexis is featured in CBS News’ Economy 4.0, highlighting our role in scaling RNA therapeutics through the ECO Synthesis® Manufacturing Platform—a cleaner, more efficient enzymatic approach transforming therapeutic manufacturing. Watch now [H2] Making the Impossible, Manufacturable With everything from next-gen RNA medicine manufacturing to pharma biocatalysis and precision bespoke enzymes, we turn theoretical therapies into life-changing realities. When timing is critical, the status quo isn’t good enough. Our enzyme-enabled platforms replace outdated methods with faster, cleaner, scalable solutions that unlock your path to market. Discover how we do it [H2] Unlock Therapeutic Possibilities at Scale We Make Complex Science Scalable with Enzyme-powered Solutions that Deliver Real-World Therapeutic Impact. RNA manufacturing Pharma biocatalysis Molecular biology and diagnostic applications See Our Solutions [H2] RNA manufacturing Evolve beyond traditional chemistry with a modern and efficient approach that slots seamlessly into your existing process. Our enzyme-enabled RNA manufacturing platform delivers superior quality, higher yield, better manufacturability and faster results — through a greener solution. A future you can believe in, sooner than you thought possible. Learn more [H2] Pharma biocatalysis Transform complex, resource-intensive processes into precise, efficient and sustainable breakthroughs. Our proprietary enzymes — powered by CodeEvolver® Technology Platform — enable greener processes, faster pathways and world-class quality from grams to tonnes. Unlock new possibilities with pharma biocatalysisand elevate your process with sustainable chemistry designed to optimize API synthesis. Learn more [H2] Molecular biology and diagnostic applications Codexis redefines enzyme performance for molecular biology and diagnostic applications. Our CodeEvolver® platform enables tailored enzyme solutions with improved fidelity, enhanced selectivity, and increased activity, delivering faster reaction times to power your applications. As your trusted partner for enzyme evolution, we deliver precision-optimized solutions that power performance. Learn more [IMG: graphic] [H2] Start the conversation with Codexis We meet you where you are and help you scale from there. Get in touch [IMG: graphic] [H2] With Proven Science, Nothing is Unreachable. We pioneered enzyme optimization for therapeutics and kept evolving it. Our proprietary platforms pair deep enzymology with machine learning to deliver scalable, sustainable solutions others can’t replicate. When others were experimenting, we were building the benchmark. Learn About Our Platform [H2] Explore Real-World Solutions See how Codexis has helped partners accelerate delivery of complex, high-value therapeutics. Browse Technical Content Presentation [H3] Enabling In-Process Control with Analytical Monitoring After Each Cycle Learn more Presentation [H3] Scaling RNA Therapeutics Sustainably Learn more eBook [H3] Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis Learn more Poster [H3] Enzymes to Enable a Biocatalytic Cascade for Small Molecule API Learn more Poster [H3] Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis Learn more Webinar [H3] Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis Learn more
4271 chars
SUB-PAGE (https://codexis.com/expert-solutions/) Expert Solutions | Codexis Services | siRNA Therapeutics
Home / Expert Solutions [H1] Expert Solutions Built on Innovation We deliver solutions that outperform legacy methods — enabling better outcomes in therapeutic siRNA manufacturing, pharma biocatalysis, and molecular biology and diagnostic applications. With over two decades of expertise and industry-defining science built in, Codexis’ services deliver solutions that scale with precision and impact. Solutions [H3] RNA Manufacturing Services Evolve beyond solid-phase oligonucleotide synthesis (SPOS) with a modern and efficient approach that delivers higher quality, greater scale, and better manufacturability Learn more Solutions [H3] Pharma Biocatalysis Transform complex, resource-intensive processes into precise, sustainable breakthroughs with biocatalysis that scales from grams to tonnes Learn more Solutions [H3] Molecular Biology and Diagnostic Applications Precision-tuned enzyme solutions enhance fidelity, selectivity, and activity for applications that demand superior performance Learn more [H3] 20+ years Of enzyme engineering expertise [H3] 16+ drugs Approved with Codexis enzymes [H3] 250+ patents Issued or pending worldwide [H3] 100+ enzymes Engineered to perform [H3] 8 and counting ACS Green Chemistry Awards [H2] Answering Your Key Questions Need more clarity on what we offer or how we can support your project? From timelines to IP flexibility, our FAQs cover common questions we hear from teams like yours. If you don’t find the information you’re looking for, just get in touch — we’re happy to help. Still have questions? Get in touch with our experts to find out more Contact us [H3] What industries do you serve? We support pharma and biotech innovators across RNA therapeutics, pharma biocatalysis, and molecular biology & diagnostics — with enzyme-powered solutions that scale. [H3] Which stages of development and manufacturing can Codexis support? From pilot run to commercial scale production, our team provides consultative services across the manufacturing continuum. [H3] Do you offer flexible IP models? Yes. We offer partnership structures with flexible IP ownership options — supporting your long-term strategy and commercial goals. [H3] What is the ECO Synthesis® Manufacturing Platform? Our proprietary RNA synthesis platform integrates enzymatic sequential synthesis and ligation workflows to deliver scalable, sustainable, and modular manufacturing of RNA therapeutics. Learn more [H2] The Scientific Legacy Behind the Solution We’ve spent over 20+ years refining the science of enzyme engineering and redefining its potential. From proven manufacturing platforms to custom molecular solutions, our technologies have helped bring 16+ approved drugs to market. We bring unmatched depth, precision, and performance to every partnership. Learn more about the scientific legacy behind Codexis [H2] Platforms Built for Technical Edge Our proprietary platforms are precision-built to scale where traditional chemistry can’t. [H3] ECO Synthesis® Manufacturing Platform A modern, scalable RNA manufacturing platform that delivers quality, scalability, and sustainability. Learn more [H3] CodeEvolver® Technology Platform The engine powering scalable solutions others can’t replicate — powered by AI, machine learning, and deep enzymology expertise. Learn more [H2] Explore Industry-Transforming Innovation Discover how we create solutions for challenges once thought unsolvable. Explore our technical content Presentation [H3] Enabling In-Process Control with Analytical Monitoring After Each Cycle Learn more Presentation [H3] Scaling RNA Therapeutics Sustainably Learn more eBook [H3] Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis Learn more Poster [H3] Enzymes to Enable a Biocatalytic Cascade for Small Molecule API Learn more Poster [H3] Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis Learn more Webinar [H3] Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis Learn more [IMG: graphic] [H2] We're Paving Your Path to the Future You own the product and we own the path. Together, we’ll take it to market clearly, cleanly and without surprises. Get in touch [IMG: graphic]
4752 chars
SUB-PAGE · THIN (https://codexis.com/contact-us/) Contact Us | Codexis Address | Codexis
Home / Contact Us [H1] The Partner for Progress Whether you need full support or targeted input, we meet you where it matters — offering expert guidance, real partnership, and solutions that scale with your needs. Contact Codexis today. [H2] Address 200 Penobscot Drive Redwood City, California 94063 650-421-8100 [H2] Sales Inquires sales@codexis.com [H2] Media Inquires media@codexis.com
451 chars
SUB-PAGE (https://codexis.com/transformational-technologies/) Transformational Technologies | CodeEvolver® | Codexis
Home / Transformational Technologies [H1] Modernizing Manufacturing for What's Next Manufacturing solutions once thought unsolvable — powered by ECO Synthesis® Manufacturing Platform and CodeEvolver® Technology Platform. [IMG: graphic] [H2] Every Capability is Intentionally Engineered for Technical Edge It’s not plug-and-play. It’s precision-built. Our proprietary platforms combine deep enzymology with AI and machine learning to deliver smarter science and repeatable success. From process transformation to product viability, we modernize manufacturing with platforms engineered for what others can’t replicate. [H2] Platforms Built on Industry-Defining Science Our proprietary transformational technologies pair enzyme know-how with machine learning, delivering smarter science and repeatable success that scales. [H3] CodeEvolver Technology Platform Driving enzyme performance with proprietary AI and machine learning — for screening kits, panels, and bespoke enzymes for small molecule APIs and molecular biology and diagnostic applications. Learn more [H3] ECO Synthesis Manufacturing Platform Enabling greener, scalable RNA manufacturing. With improved yield, quality, and manufacturability, while increasing sustainability for next-gen oligonucleotide-based therapies. Learn more [H2] Combining Bold Innovation with Scientific Legacy We’ve spent over 20 years refining the science of enzyme engineering and pushing the boundaries of therapeutic manufacturing. Our legacy of innovation — proven across platforms, programs, and partnerships — powers the next generation of real-world solutions. Learn more about our legacy [H2] Explore Our Engineered Advantage Learn more about how our proprietary approach delivers results other platforms can’t replicate. View all technical resources Presentation [H3] Enabling In-Process Control with Analytical Monitoring After Each Cycle Learn more Presentation [H3] Scaling RNA Therapeutics Sustainably Learn more eBook [H3] Unlocking the Future of RNA Manufacturing: A Guide to Enzymatic Synthesis Learn more Poster [H3] Enzymes to Enable a Biocatalytic Cascade for Small Molecule API Learn more Poster [H3] Machine Learning-Guided Ligation Fragment Design for Efficient siRNA Synthesis Learn more Webinar [H3] Comparative Analysis of Diastereomeric Distribution in siRNA Synthesis: SPOS vs Enzymatic Synthesis Learn more [IMG: graphic] [H2] Discover the Engine Powering Scalable Solutions Learn more about how our proprietary approach offers solutions that others can’t replicate. Let’s talk. Get in touch [IMG: graphic]
2879 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
8Review mentions (all pages)
0External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 2 | 0 |
| /expert-solutions/ | 2 | 0 |
| /contact-us/ | 2 | 0 |
| /transformational-technologies/ | 2 | 0 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.codexis.com/",
"url": "https://www.codexis.com/",
"name": "Codexis | RNA Manufacturer | Enzyme Biocatalysis Solutions",
"isPartOf": {
"@id": "https://www.codexis.com/#website"
},
"datePublished": "2025-08-01T09:11:32+00:00",
"dateModified": "2026-03-04T15:45:30+00:00",
"description": "Codexis: RNA manufacturing and custom enzyme engineering for pharmaceuticals and siRNA therapeutics.",
"breadcrumb": {
"@id": "https://www.codexis.com/#breadcrumb"
},
"inLanguage": "en-GB",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.codexis.com/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.codexis.com/#breadcrumb",
"itemListElement": []
},
{
"@type": "WebSite",
"@id": "https://www.codexis.com/#website",
"url": "https://www.codexis.com/",
"name": "Codexis",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.codexis.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-GB"
}
]
}
/expert-solutions/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.codexis.com/expert-solutions/",
"url": "https://www.codexis.com/expert-solutions/",
"name": "Expert Solutions | Codexis Services | siRNA Therapeutics",
"isPartOf": {
"@id": "https://www.codexis.com/#website"
},
"datePublished": "2025-08-10T14:28:16+00:00",
"dateModified": "2026-01-30T04:58:42+00:00",
"description": "Explore Codexis' expert solutions in siRNA therapeutics and enzyme engineering for pharma.",
"breadcrumb": {
"@id": "https://www.codexis.com/expert-solutions/#breadcrumb"
},
"inLanguage": "en-GB",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.codexis.com/expert-solutions/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.codexis.com/expert-solutions/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.codexis.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Expert Solutions"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.codexis.com/#website",
"url": "https://www.codexis.com/",
"name": "Codexis",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.codexis.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-GB"
}
]
}
/contact-us/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.codexis.com/contact-us/",
"url": "https://www.codexis.com/contact-us/",
"name": "Contact Us | Codexis Address | Codexis",
"isPartOf": {
"@id": "https://www.codexis.com/#website"
},
"datePublished": "2025-08-10T14:29:52+00:00",
"dateModified": "2025-10-13T20:20:59+00:00",
"description": "Contact Codexis for locations, address information, partnership opportunities or any other questions you may have.",
"breadcrumb": {
"@id": "https://www.codexis.com/contact-us/#breadcrumb"
},
"inLanguage": "en-GB",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.codexis.com/contact-us/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.codexis.com/contact-us/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.codexis.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Contact Us"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.codexis.com/#website",
"url": "https://www.codexis.com/",
"name": "Codexis",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.codexis.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-GB"
}
]
}
/transformational-technologies/
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.codexis.com/transformational-technologies/",
"url": "https://www.codexis.com/transformational-technologies/",
"name": "Transformational Technologies | CodeEvolver® | Codexis",
"isPartOf": {
"@id": "https://www.codexis.com/#website"
},
"datePublished": "2025-08-10T14:28:59+00:00",
"dateModified": "2026-01-30T05:12:05+00:00",
"description": "Discover Codexis' innovative technologies which include our CodeEvolver® platform and our ECO Synthesis™ Technology.",
"breadcrumb": {
"@id": "https://www.codexis.com/transformational-technologies/#breadcrumb"
},
"inLanguage": "en-GB",
"potentialAction": [
{
"@type": "ReadAction",
"target": [
"https://www.codexis.com/transformational-technologies/"
]
}
]
},
{
"@type": "BreadcrumbList",
"@id": "https://www.codexis.com/transformational-technologies/#breadcrumb",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.codexis.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Transformational Technologies"
}
]
},
{
"@type": "WebSite",
"@id": "https://www.codexis.com/#website",
"url": "https://www.codexis.com/",
"name": "Codexis",
"description": "",
"potentialAction": [
{
"@type": "SearchAction",
"target": {
"@type": "EntryPoint",
"urlTemplate": "https://www.codexis.com/?s={search_term_string}"
},
"query-input": {
"@type": "PropertyValueSpecification",
"valueRequired": true,
"valueName": "search_term_string"
}
}
],
"inLanguage": "en-GB"
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS
Based on 784 businesses audited.
✓ Less BS than average
Codexis has 0.7 points less BS than the average for Medical Devices, Pharma & Biotech.
BS Detector
Medical Devices, Pharma & Biotech BS: Codexis (codexis.com)
https://codexis.com
📍 Industry: Medical Devices, Pharma & Biotech
40
BS / 100
Codexis is a technically legitimate biotech entity that dilutes its own authority with high-gloss marketing fluff and a lack of transparent, external verification. It successfully proves ‘what’ it does through proprietary platform names, but fails to prove ‘who’ does it or ‘exactly’ whom they have done it for.
Info Density
Power-words vs. Substance ratio.
9
30% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
14
70% BS
Commodity Fingerprint
Detection of industry clichés/templates.
8
53% BS
Identity & Authority
Expert verifiability & Schema depth.
8
53% BS
Replace generic H2 headings like ‘Answering Your Key Questions’ with outcome-specific headers. Implement Person and Organization schema with sameAs links to the company’s LinkedIn and key scientists’ profiles. Provide a specific, searchable list of patent numbers to substantiate the ‘250+ patents’ claim. Add external links to the 8 ACS Green Chemistry Award announcements to move proof from internal claims to third-party verification.
The website content perfectly aligns with the Medical Devices, Pharma & Biotech category. The presence of specialized terminology such as siRNA therapeutics, biocatalysis, and enzymatic synthesis confirms a deep involvement in pharmaceutical manufacturing and biotechnology.
“The score of 40 is primarily driven by Trust and Proof (14) and Identity and Authority gaps (8). The lack of verifiable external links and named human experts offsets the high technical substance of the proprietary platform descriptions. The site avoids a higher BS score due to its consistent messaging and specific technical metrics.”
Verified Analysis Date: May 29, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from Codexis, captured on May 29, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Codexis: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://codexis.com to view the most current version of its content and learn from the source what this company is about and what it offers.